Irhythm Holdings, Inc. current report, 22 September 2026

Vollständiges Dokument

iRhythm Holdings, Inc. Form 8-K Summary

Business Context and Reporting Period

iRhythm Holdings, Inc. filed a Current Report on Form 8-K dated September 22, 2026, under Item 7.01, Regulation FD Disclosure. The filing updates the status of iRhythm’s proposed acquisition of Vital Connect, Inc.

Transaction Update

  • On August 5, 2026, iRhythm Technologies, Inc., a wholly owned subsidiary of iRhythm Holdings, entered into a merger agreement to acquire Vital Connect through a subsidiary merger.
  • The Hart-Scott-Rodino antitrust waiting period expired at 11:59 p.m. Eastern Time on September 18, 2026.
  • The acquisition is currently anticipated to close in early October 2026, subject to customary closing conditions being satisfied or waived.

Financial Metrics and Liquidity

The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, purchase-price, financing, or other quantitative financial information.

Material Changes Versus the Prior Comparable Period

The filing does not present period-over-period financial results. The material update is the expiration of the antitrust waiting period and the anticipated early October 2026 closing of the Vital Connect acquisition.

Outlook, Risks, and Unusual Items

  • The expected closing date is forward-looking and remains subject to customary closing conditions.
  • The acquisition may not be completed on the anticipated terms or timing.
  • The company refers investors to risk factors and other disclosures in its SEC filings.
  • The filing’s Regulation FD disclosure is furnished, not filed for purposes of Section 18 of the Exchange Act, and is not incorporated by reference into other filings except where expressly stated.

Important Facts for Investors to Verify

  1. Whether all remaining closing conditions for the Vital Connect acquisition are satisfied or waived.
  2. The final closing date and any changes to the announced transaction terms.
  3. The acquisition consideration, financing sources, and expected effect on iRhythm’s cash, debt, expenses, and future financial results, which are not provided in this filing.
  4. Any subsequent SEC filing reporting completion, termination, or modification of the transaction.